Healthcare IBD - Summary & Resources
####WSO resources
[Healthcare Overview](https://www.wallstreetoasis.com/forums/healthcare…)
[Biotech Finance: From IB to VC / HF to Funded Startup (Part 1)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Biotech Finance: Valuation Methodologies And Modeling Considerations (Part 2)](https://www.wallstreetoasis.com/forums/biotech-fi…)
[Q&A: BB IBD Healthcare Analyst](https://www.wallstreetoasis.com/forums/q&a-bb-ibd…)
[Questions About Healthcare M&A](https://www.wallstreetoasis.com/forums/questions-…)
[Guide to Evaluate a Biotech Company](https://www.wallstreetoasis.com/forums/guide-to-e…)
####External resources (news and reports)
[FierceBiotech](https://www.fiercebiotech.com/)
[FiercePharma](https://www.fiercepharma.com/)
[Biospace](https://www.biospace.com/news/)
[WSJ Health](https://www.wsj.com/news/business/health-industry)
[Medscape](https://www.medscape.com/)
[Bain's Global Healthcare Private Equity and Corporate M&A reports][]
[Paul Keckley's weekly report](https://www.paulkeckley.com/the-keckley-report)
[Axios Vitals](https://www.axios.com/newsletters/axios-vitals)
Medical device industry:
[Fierce MedTech](https://www.fiercebiotech.com/medtech)
[MassDevice](https://www.massdevice.com/)
[Medical Device Manufacturers Association](https://www.medicaldevices.org/news/)
####Books
**- "The Pharmagellan Guide to Biotech Forecasting and Valuation"**
**- "Biotechnology Valuation", Karl Kleegan**: Chapter 3 is about the drug development process. You can also check Chapter 4 to learn how to build a disease model. However, read this book only if you already know valuation (DCF, comps), because the author uses quick-n-dirty or overly complex techniques that you shouldn't follow as an investment banker (he was an ER guy).
####Graphic on the industry
!PHARMA(https://www.wallstreetoasis.com/files/styles/w800…)
####Bonus videos
*How To Analyze a Clinical Trial:* not directly related to IB, but still interesting in order to understand how clinical trials work and the effect of their results on share price
[Part 1](
[Part 2](https://www.youtube.com/watch?v=A-hYVtCA06c)
[Part 3]()
[Part 4](https://www.youtube.com/watch?v=_aO5BhyEgXo)
Anything I should add?
**Thanks to TheFlyingKiwi(https://www.wallstreetoasis.com/user/423544)!**
[Bain's Global Healthcare Private Equity and Corporate M&A reports]: https://www.bain.com/insights/topics/global-healt…
[Medscape]: https://www.medscape.com/
Solid thread. +1 and following.
I'd add https://www.paulkeckley.com/the-keckley-report</a">Paul Keckley's weekly report to the ex resources. He does great political analysis and provides insight from government and survey data.
https://www.medscape.com/</a">Medscape
https://www.fiercebiotech.com/medtech</a">Fierce MedTech
https://www.massdevice.com/</a">Mass Device
WSJ Health
https://www.medicaldevices.org/news/</a">Med Dev Manufacturers Assoc (I just follow the Twitter account)
WSO:
https://www.wallstreetoasis.com/forums/biotech-finance-part-2-valuation…</a">Biotech Finance Part 2: Valuation Methodologies And Modeling Considerations
https://www.wallstreetoasis.com/forums/guide-to-evaluate-a-biotech-comp…</a">Guide To Evaluate A Biotech Company
Nice graphic on the industry.
Can't think of anymore off the top of my head. Looking forward to what others say as well.
I'm adding your links, thanks!
Cheers! Would be interested if other users follow any individual Twitter accounts that posts good insights/knowledge. Always hard to find those.
bump
bump
bump
bump
Bump
Bump
Bump
Bump
Bump
https://www.mobihealthnews.com/
I work in HCIT corporate right now and read a lot from this website as well as CB Insights Digital Health (very solid). Pretty sure HW or HL has a public report about HCIT companies in 2020 (fairly in depth, similar to CB Insights).
Associate exit opps?
bump
Bump
wondering if anyone has any good healthcare business books?
Bump
B
B
Vero est at voluptates reprehenderit quisquam. Quo incidunt praesentium dolore molestiae architecto. Saepe voluptas velit officia non non rem. Reprehenderit eaque quis delectus id cum quia. Totam et voluptates laborum magnam qui est culpa. Odit ut quo nostrum quis tempora voluptatum quo. Ex labore rem ut earum ut voluptas.
Quod aspernatur minus adipisci ipsam ut. Vitae cupiditate tempora consequatur dolorem. Porro pariatur ad et. Sunt vel excepturi tempore excepturi est. Ipsa ipsa ducimus molestiae commodi. Cupiditate non distinctio in velit et.
Tenetur dolores dolorum sed totam voluptas. Qui modi cumque dolorem sit veritatis explicabo consequuntur. Voluptatibus est quam sint quam ut laboriosam. Repudiandae dolor temporibus laboriosam ut explicabo dolores animi.
Non quidem enim quaerat ut. Voluptates sed quasi rerum quis veniam corporis nobis. Ad libero ea ut quia quos. Nam saepe necessitatibus et eveniet aliquam aperiam doloremque aut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Facere at perspiciatis dolorum atque aliquam ut. Totam saepe voluptatem perferendis consequatur quia quia ratione. Molestias voluptas aut dicta quae possimus earum velit.
Minus animi laborum enim ut qui eum corrupti et. Consequatur dicta quia doloribus officia illum quia deserunt.
Corrupti tenetur tenetur dolores. Temporibus eos quam dolores maxime ipsum aspernatur. Odio magni et quis voluptatum doloribus enim.